Published in Clin Cancer Res on July 02, 2012
Are outcome-adaptive allocation trials ethical? Clin Trials (2015) 4.68
Simulation study for evaluating the performance of response-adaptive randomization. Contemp Clin Trials (2014) 1.45
Biomarker-based adaptive trials for patients with glioblastoma--lessons from I-SPY 2. Neuro Oncol (2013) 0.85
Commentary on Hey and Kimmelman. Clin Trials (2015) 0.83
Statistical controversies in clinical research: scientific and ethical problems with adaptive randomization in comparative clinical trials. Ann Oncol (2015) 0.80
A Bayesian adaptive design for biomarker trials with linked treatments. Br J Cancer (2015) 0.79
Adaptive clinical trial designs in oncology. Chin Clin Oncol (2014) 0.79
Bayesian Two-stage Biomarker-based Adaptive Design for Targeted Therapy Development. Stat Biosci (2014) 0.76
Ethical challenges in conducting clinical research in lung cancer. Transl Lung Cancer Res (2016) 0.75
Managing competing demands in the implementation of response-adaptive randomization in a large multicenter phase III acute stroke trial. Stat Med (2014) 0.75
A simulation study of outcome adaptive randomization in multi-arm clinical trials. Clin Trials (2017) 0.75
Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics (1975) 18.25
STREPTOMYCIN treatment of pulmonary tuberculosis. Br Med J (1948) 12.23
The BATTLE trial: personalizing therapy for lung cancer. Cancer Discov (2011) 7.57
Outcome--adaptive randomization: is it useful? J Clin Oncol (2010) 4.81
Generation of allocation sequences in randomised trials: chance, not choice. Lancet (2002) 4.35
Bayesian adaptive design for targeted therapy development in lung cancer--a step toward personalized medicine. Clin Trials (2008) 2.71
Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. Stat Med (1995) 2.70
Practical Bayesian adaptive randomisation in clinical trials. Eur J Cancer (2007) 2.18
Adaptive clinical trials: the promise and the caution. J Clin Oncol (2010) 2.15
Adaptive clinical trials in oncology. Nat Rev Clin Oncol (2011) 2.06
Bayesian adaptive randomization designs for targeted agent development. Clin Trials (2010) 1.74
Statistical properties of randomization in clinical trials. Control Clin Trials (1988) 1.69
A group sequential, response-adaptive design for randomized clinical trials. Control Clin Trials (2003) 1.32
Ethical issues in oncology biostatistics. Stat Methods Med Res (2002) 0.99
Adaptive randomization for multiarm comparative clinical trials based on joint efficacy/toxicity outcomes. Biometrics (2009) 0.94
A Bayesian adaptive design with biomarkers for targeted therapies. Clin Trials (2010) 0.94
On the usefulness of outcome-adaptive randomization. J Clin Oncol (2011) 0.90
Block response-adaptive randomization in clinical trials with binary endpoints. Pharm Stat (2010) 0.84
Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity. Lifetime Data Anal (2010) 0.81
Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet (2012) 10.53
Genome-wide association study identifies susceptibility loci for IgA nephropathy. Nat Genet (2011) 3.15
ATG12 conjugation to ATG3 regulates mitochondrial homeostasis and cell death. Cell (2010) 2.83
Multitarget therapy for induction treatment of lupus nephritis: a randomized trial. Ann Intern Med (2015) 1.99
Role of the retinoic acid receptor-α in HIV-associated nephropathy. Kidney Int (2010) 1.89
Crystal structure and functional analysis of Dcp2p from Schizosaccharomyces pombe. Nat Struct Mol Biol (2005) 1.88
A systems approach identifies HIPK2 as a key regulator of kidney fibrosis. Nat Med (2012) 1.83
Interactions between Nef and AIP1 proliferate multivesicular bodies and facilitate egress of HIV-1. Retrovirology (2006) 1.71
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung. PLoS One (2010) 1.69
Geographic differences in genetic susceptibility to IgA nephropathy: GWAS replication study and geospatial risk analysis. PLoS Genet (2012) 1.69
Structural basis of dcp2 recognition and activation by dcp1. Mol Cell (2008) 1.65
HER family receptor abnormalities in lung cancer brain metastases and corresponding primary tumors. Clin Cancer Res (2009) 1.61
HIV-specific cytotoxic T cells from long-term survivors select a unique T cell receptor. J Exp Med (2004) 1.60
Functional analysis of promoter mutations in the ACTN4 and SYNPO genes in focal segmental glomerulosclerosis. Nephrol Dial Transplant (2009) 1.58
Crystal structure of Dcp1p and its functional implications in mRNA decapping. Nat Struct Mol Biol (2004) 1.57
Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials. Clin Cancer Res (2007) 1.54
Protein corona-mediated mitigation of cytotoxicity of graphene oxide. ACS Nano (2011) 1.53
Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. ACS Nano (2011) 1.52
Efficacy and safety of traditional chinese medicine (Shenqi particle) for patients with idiopathic membranous nephropathy: a multicenter randomized controlled clinical trial. Am J Kidney Dis (2013) 1.50
Contrast-induced nephropathy in patients with chronic kidney disease undergoing computed tomography: a double-blind comparison of iodixanol and iopamidol. Invest Radiol (2006) 1.43
Renal involvement and followup of 130 patients with primary Sjögren's syndrome. J Rheumatol (2007) 1.43
A multiscale model of thrombus development. J R Soc Interface (2008) 1.42
Comparison of the sensitivity and specificity of 5 image sets of dual-energy computed tomography for detecting first-pass myocardial perfusion defects compared with positron emission tomography. Medicine (Baltimore) (2014) 1.38
HIV-1 Nef disrupts the podocyte actin cytoskeleton by interacting with diaphanous interacting protein. J Biol Chem (2008) 1.38
A multicenter application and evaluation of the oxford classification of IgA nephropathy in adult chinese patients. Am J Kidney Dis (2012) 1.32
Predicting progression of IgA nephropathy: new clinical progression risk score. PLoS One (2012) 1.30
Sequential continual reassessment method for two-dimensional dose finding. Stat Med (2008) 1.28
Emerging trends in the performance of parathyroid surgery. Laryngoscope (2007) 1.26
Mycophenolate mofetil in induction and maintenance therapy of severe lupus nephritis: a meta-analysis of randomized controlled trials. Nephrol Dial Transplant (2007) 1.24
The biocompatibility of nanodiamonds and their application in drug delivery systems. Theranostics (2012) 1.22
Marginal analysis of correlated failure time data with informative cluster sizes. Biometrics (2007) 1.22
Phase I study of capecitabine in combination with temozolomide in the treatment of patients with brain metastases from breast carcinoma. Cancer (2006) 1.20
Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study. J Am Soc Nephrol (2013) 1.20
BAYESIAN PHASE I/II ADAPTIVELY RANDOMIZED ONCOLOGY TRIALS WITH COMBINED DRUGS. Ann Appl Stat (2011) 1.17
Knockdown of Stat3 activity in vivo prevents diabetic glomerulopathy. Kidney Int (2009) 1.15
Simultaneous detection of influenza A, influenza B, and respiratory syncytial viruses and subtyping of influenza A H3N2 virus and H1N1 (2009) virus by multiplex real-time PCR. J Clin Microbiol (2011) 1.14
Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis. Nephrol Dial Transplant (2011) 1.12
Maternal executive function, harsh parenting, and child conduct problems. J Child Psychol Psychiatry (2012) 1.12
Randomized controlled trial of icodextrin versus glucose containing peritoneal dialysis fluid. Clin J Am Soc Nephrol (2009) 1.10
Root canal filled versus non-root canal filled teeth: a retrospective comparison of survival times. J Public Health Dent (2005) 1.09
microRNA-124 regulates cardiomyocyte differentiation of bone marrow-derived mesenchymal stem cells via targeting STAT3 signaling. Stem Cells (2012) 1.08
HIV-1 Nef down-regulates the hemochromatosis protein HFE, manipulating cellular iron homeostasis. Proc Natl Acad Sci U S A (2005) 1.07
25th anniversary article: CVD polymers: a new paradigm for surface modification and device fabrication. Adv Mater (2013) 1.04
Coexistence of normotensive primary aldosteronism in two patients with Gitelman's syndrome and novel thiazide-sensitive Na-Cl cotransporter mutations. Eur J Endocrinol (2009) 1.04
Robust EM Continual Reassessment Method in Oncology Dose Finding. J Am Stat Assoc (2011) 1.03
Phase 3 study comparing the use of docetaxel on an every-3-week versus weekly schedule in the treatment of metastatic breast cancer. Cancer (2008) 1.03
Coiled versus straight peritoneal dialysis catheters: a randomized controlled trial and meta-analysis. Am J Kidney Dis (2011) 1.02
Mineral and bone disorder in Chinese dialysis patients: a multicenter study. BMC Nephrol (2012) 1.02
The PREDICT study: a randomized double-blind comparison of contrast-induced nephropathy after low- or isoosmolar contrast agent exposure. AJR Am J Roentgenol (2008) 1.01
Polyvalent immunostimulatory nanoagents with self-assembled CpG oligonucleotide-conjugated gold nanoparticles. Angew Chem Int Ed Engl (2011) 0.99
Bayesian hybrid dose-finding design in phase I oncology clinical trials. Stat Med (2011) 0.99
Macroscopic dynamics of biological cells interacting via chemotaxis and direct contact. Phys Rev E Stat Nonlin Soft Matter Phys (2008) 0.99
Asian chronic kidney disease best practice recommendations: positional statements for early detection of chronic kidney disease from Asian Forum for Chronic Kidney Disease Initiatives (AFCKDI). Nephrology (Carlton) (2011) 0.99
Identification and functional analysis of a novel TRPC6 mutation associated with late onset familial focal segmental glomerulosclerosis in Chinese patients. Mutat Res (2008) 0.99
Enhanced erythropoiesis in Hfe-KO mice indicates a role for Hfe in the modulation of erythroid iron homeostasis. Blood (2010) 0.99
Multiscale dynamics of biological cells with chemotactic interactions: from a discrete stochastic model to a continuous description. Phys Rev E Stat Nonlin Soft Matter Phys (2006) 0.99
Dose-response curve estimation: a semiparametric mixture approach. Biometrics (2011) 0.98
Methylation of the candidate biomarker TCF21 is very frequent across a spectrum of early-stage nonsmall cell lung cancers. Cancer (2010) 0.97
Graphene fibers with predetermined deformation as moisture-triggered actuators and robots. Angew Chem Int Ed Engl (2013) 0.97
Bayesian quantile regression for longitudinal studies with nonignorable missing data. Biometrics (2009) 0.97
Two-photon intravital imaging of thrombus development. J Biomed Opt (2010) 0.97
Novel SLC12A3 mutations in Chinese patients with Gitelman's syndrome. Nephron Physiol (2008) 0.96
Mechanism of the cytotoxicity of the diazoparaquinone antitumor antibiotic kinamycin F. Free Radic Biol Med (2007) 0.96
MicroRNA-204-5p regulates epithelial-to-mesenchymal transition during human posterior capsule opacification by targeting SMAD4. Invest Ophthalmol Vis Sci (2013) 0.96
Permanent Genetic Resources added to Molecular Ecology Resources Database 1 December 2009-31 January 2010. Mol Ecol Resour (2010) 0.95
Phase II trial design with Bayesian adaptive randomization and predictive probability. J R Stat Soc Ser C Appl Stat (2012) 0.95
Moisture-activated torsional graphene-fiber motor. Adv Mater (2014) 0.94
Correlation between gastrointestinal fungi and varying degrees of chronic hepatitis B virus infection. Diagn Microbiol Infect Dis (2010) 0.94
dfrA27, a new integron-associated trimethoprim resistance gene from Escherichia coli. J Antimicrob Chemother (2008) 0.94
Novel clinical trial designs for treatment of ductal carcinoma in situ of the breast with trastuzumab (herceptin). Breast J (2007) 0.93
Textile electrodes woven by carbon nanotube-graphene hybrid fibers for flexible electrochemical capacitors. Nanoscale (2013) 0.92
Peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonists attenuate the profibrotic response induced by TGF-beta1 in renal interstitial fibroblasts. Mediators Inflamm (2007) 0.92
Glutathione-s-transferase-pi expression in early breast cancer: association with outcome and response to chemotherapy. Cancer Invest (2010) 0.92
Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin/NFATc3 pathway. Int J Biol Sci (2011) 0.91
Bayesian two-step Lasso strategy for biomarker selection in personalized medicine development for time-to-event endpoints. Contemp Clin Trials (2013) 0.90
On the usefulness of outcome-adaptive randomization. J Clin Oncol (2011) 0.90
High-frequency variant p.T60M in NaCl cotransporter and blood pressure variability in Han Chinese. Am J Nephrol (2012) 0.90
Changing spectrum of biopsy-proven primary glomerular diseases over the past 15 years: a single-center study in China. Contrib Nephrol (2013) 0.90
The regulation of testicular descent and the effects of cryptorchidism. Endocr Rev (2013) 0.89
Continuous macroscopic limit of a discrete stochastic model for interaction of living cells. Phys Rev Lett (2007) 0.88
Role of P-selectin and anti-P-selectin monoclonal antibody in apoptosis during hepatic/renal ischemia reperfusion injury. World J Gastroenterol (2000) 0.88
Identification of five novel variants in the thiazide-sensitive NaCl co-transporter gene in Chinese patients with Gitelman syndrome. Nephrology (Carlton) (2009) 0.87
Propylthiouracil-associated antineutrophil cytoplasmic autoantibody-positive vasculitis: retrospective study of 19 cases. J Rheumatol (2007) 0.87
Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model. Lab Invest (2013) 0.87
Probabilistic MRI brain anatomical atlases based on 1,000 Chinese subjects. PLoS One (2013) 0.87
Graphene-based fibers for supercapacitor applications. Nanotechnology (2015) 0.87
Escalation with overdose control for phase I drug-combination trials. Stat Med (2013) 0.87
PPAR-gamma agonists inhibit TGF-beta1-induced chemokine expression in human tubular epithelial cells. Acta Pharmacol Sin (2008) 0.86
Architecture of CuS/PbS heterojunction semiconductor nanowire arrays for electrical switches and diodes. Inorg Chem (2012) 0.86
[Analysis of drug-induced acute renal failure in Shanghai]. Zhonghua Yi Xue Za Zhi (2009) 0.86
Designed diblock oligonucleotide for the synthesis of spatially isolated and highly hybridizable functionalization of DNA-gold nanoparticle nanoconjugates. J Am Chem Soc (2012) 0.86
The Difference of Clinical Characteristics Between Patients With Exon 19 Deletion and Those With L858R Mutation in Nonsmall Cell Lung Cancer. Medicine (Baltimore) (2015) 0.86
Nanoparticle cluster gas sensor: Pt activated SnO2 nanoparticles for NH3 detection with ultrahigh sensitivity. Nanoscale (2015) 0.86
Pilot 24 month study to compare mycophenolate mofetil and tacrolimus in the treatment of membranous lupus nephritis with nephrotic syndrome. Nephrology (Carlton) (2012) 0.85
Spleen size measured on enhanced MRI for quantitatively staging liver fibrosis in minipigs. J Magn Reson Imaging (2013) 0.85
Expression of HER-2 in rectal cancers treated with preoperative radiotherapy: a potential biomarker predictive of metastasis. Dis Colon Rectum (2014) 0.85
Bacterial communities of Beijing surface waters as revealed by 454 pyrosequencing of the 16S rRNA gene. Environ Sci Pollut Res Int (2015) 0.84
Controlling growth of molecular crystal aggregates for efficient optical waveguides. Chem Commun (Camb) (2012) 0.84